Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures

Neuroscience

Volumn 108, Issue 2, 2001, Pages 273-284

  Meyer, M ^a,c   Matarredona, E R ^b   Seiler, R W ^a   Zimmer, J ^c   Widmer, H R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CÁDIZ   (Spain)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Calbindin; Dopamine; Parkinson's disease; Tissue culture

Indexed keywords

CALBINDIN; DOPAMINE; ENOLASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LACTATE DEHYDROGENASE; NEUROTROPHIN 4; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EMBRYO; ENZYME ACTIVITY; ENZYME RELEASE; EXPLANT; GLIA CELL; NEUROTROPISM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL DIFFERENTIATION; CELLS, CULTURED; DOPAMINE; DRUG INTERACTIONS; FEMALE; FETUS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; NEOSTRIATUM; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PARKINSON DISEASE; PHOSPHOPYRUVATE HYDRATASE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0035842562     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00418-3     Document Type: Article

References (95)

1. Estimation of nuclear population from microtome sections
2. Neurotrophin-4/5 selectively protects nigral calbindin-containing neurons in rats with medial forebrain bundle transections
3. Calcium-binding proteins in the substantia nigra and ventral tegmental area during development: Correlation with dopaminergic compartmentalization
4. Calcium-binding proteins: Selective markers of nerve cells
5. Immunohistochemical localization of calretinin in the rat hindbrain
6. Synergistic effects of schwann- and muscle-derived factors on motoneuron survival involve GDNF and cerdiotrophin-1 (CT-1)
7. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3-Ret receptor complex
8. Purification of a new neurotrophic factor from mammalian brain
9. Differential calbindin-immunoreactivity in dopamine neurons projecting to the rat striatal complex
10. Non viral GDNF gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's disease
11. Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB
12. Lntr receptors
13. Neural transplantation for neurodegenerative disorders
14. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
15. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture
16. Calbindin D-28k and parvalbumin in the rat nervous system
17. The p75 neurotrophin receptor
18. GDNF reduces apoptosis in dopaminergic neurons in vitro
19. GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro
20. Staging and dissection of rat embryos
21. Prospects for new restorative and neuroprotective treatments in Parkinson's disease
22. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family
23. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor
24. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
25. Bilateral fetal nigral transplantation into the postcommisural putamen in Parkinson's disease
26. The neurotrophins and their receptors
27. Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system
28. Neurotrophin 6 is a new member of the nerve growth factor family
29. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum
30. Early events in neurotrophin signaling via Trk and p75 receptors
31. The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease
32. Intracellular calcium-binding proteins. More sites than insights
33. Expression of calbindin D28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: Normal distribution in Parkinson's disease
34. Rat ventral mesencephalon grown as solid tissue cultures: Influence of culture time and BDNF treatment on dopamine neuron survival and function
35. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family
36. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons
37. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of het ventral mesencephalon
38. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures
39. Mammalian neurotrophin-4: Structure, chromosomal localization, tissue distribution, and receptor specificity
40. GDNF-induced activiation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF
41. GFRα-2 and GFRα-3 are two new receptors for ligands of the GDNF family
42. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo
43. Neurotrophin signal transduction in the nervous system
44. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
45. Neurturin, a relative of glial-cell-line-derived neurotrophic factor
46. Glial cell line-derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro
47. Clevage of structural proteins during the assembly of the head of bacteriophage T4
48. Molecular cloning and expression of brain-derived neurotrophic factor
49. The nerve growth factor 35 years later
50. GDNFL: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
51. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor
52. Neurotrophic factors: From molecules to man
53. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
54. GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide
55. NT-3, BDNF, and NGF in the developing rat nervous system. Parallel as well as reciprocal patterns of expression
56. Enovin, a member of the glial cell line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants
57. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans
58. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations
59. Improved survival of embryonic porcine dopaminergic neurons in co-culture with a conditionally immortalized GDNF-producing cell line
60. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat
61. GDNF increases the density of cells containing calbindin but not of cells containing calretinin in cultured rat and human fetal nigral tissue
62. Persephin, a novel neurotrophic factor related to GDNF and Neurturin
63. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: A triple-labelling immunohistochemical study
64. Fetal nigral transplantation as a therapy for Parkinson's disease
65. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons
66. Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons
67. 3H)tyrosine by charcoal
68. Calretinin in rat brain: An immunohistochemical study
69. Immunohistochemical makers in rat brain: Colocalisation of calretinin and calbindin-D28k with tyrosine hydroxylase
70. In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin
71. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts
72. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons
73. Dopamine neurons in a simple GDNF-treated meso-striatal organotypic co-culture model
74. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts
75. Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-OHDA-lesioned rats gives rise to grafts rich in dopaminergic neurons
76. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon
77. Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon
78. Non-invasive dopamine determination by reversed phase HPLC in the medium of free floating roller tube cultures of rat fetal ventral mesencephalon
79. Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra
80. Fetal tissue transplantation in Parkinson's disease
81. The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells
82. Characterization of a multicomponent receptor for GDNF
83. Functional receptor for GDNF encoded by the c-ret proto-oncogene
84. Lactate dehydrogenase, UV-method with pyruvate and NADH
85. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro
86. Stimulation of GABAergic neuron differentiation by NT-4/5 in cultures of cerebral cortex
87. Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture
88. Rapid phosphorylation of phospholipase-Cg1 by BDNF and NT-3 in cultures of embryonic rat cortical neurons
89. Stimulation of phosphatidylinositol hydrolysis by brain-derived neurotrophic factor and neurotrophin-3 in rat cerebral cortical neurons developing in culture
90. Down regulation of phosphatidylinositol response to BDNF and NT-3 in cultures of cortical neurons
91. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured nigral calbindin and calretinin expressing neurons
92. 28K
93. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue
94. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats
95. Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro